SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cipla
Cipla
BSE: 500087|NSE: CIPLA|ISIN: INE059A01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 01, 16:00
623.25
-2.45 (-0.39%)
VOLUME 83,675
LIVE
NSE
Oct 01, 15:59
624.30
-2.5 (-0.4%)
VOLUME 1,220,240
News on Cipla
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Barring IT & pharma, Q2 earnings to disappoint: Dimensions 

10.21 am | 30 Sep 2014 |  Source: CNBC-TV18

The second quarter India Inc earnings, which will kick-off from the October 10 could be a disappointment barring IT and pharma companies, Ajay Srivast...

Discussing partnerships, have done in-licensing deals:Cipla 

7.11 pm | 29 Sep 2014 |  Source: CNBC-TV18

The company's CEO, Subhanu Saxena, in an exclusive conversation with CNBC-TV18's Archana Shukla says the focus is on building the company for the long...

Cipla strengthens its presence in Kenya

1.00 pm | 29 Sep 2014 |  Source: Moneycontrol.com

Cipla today announced that the company aims to build a strong presence in Kenya. The company has recently introduced its own office in Kenya. The prod...

See resistance at 8,000-8,100; like pharma, auto: Expert 

6.27 pm | 26 Sep 2014 |  Source: CNBC-TV18

Rahul Mohinder of viratechindia.com feels Cipla and Dr Reddy’s should continue to do well. In the auto sector, he is positive on M&M and Bajaj Auto....

Here are top 10 stocks to keep an eye on Sep 26 

8.31 am | 26 Sep 2014 |  Source: CNBC-TV18

Here are top 10 stocks to keep an eye on Sep 26 - Bharti Airtel, GMR Infra, Aurobindo Pharma, Cipla, JP Associates, JP Power, JSW Energy, Petronet LNG...

Stocks in news: JSW Energy, JP Power, Cipla, Petronet, MCX

8.27 am | 26 Sep 2014 |  Source: CNBC-TV18

SBI | Coal India | Hindalco Industries | JSW Energy | Cipla | Jaiprakash Power Ventures | Adani Power | JK Tyre | City Union Bank | Bajaj Hindusthan |...

Cipla will retest Rs 630-640: Hemant Thukral 

10.55 am | 25 Sep 2014 |  Source: CNBC-TV18

Hemant Thukral of Aditya Birla Money is of the view that Cipla will retest Rs 630-640....

Oct expiry to be stable, close above 8000: Hemant Thukral 

9.32 am | 25 Sep 2014 |  Source: CNBC-TV18

Hemant Thukral of Aditya Birla Money expects the November series to be positive as the sentiment is strong....

Super Six: Top chart picks for September 25

8.22 am | 25 Sep 2014 |  Source: CNBC-TV18

Shrikant Chouhan of Kotak Securities advises buying Cipla with a target of Rs 630-640 and Gujarat State Fertilizers & Chemicals with a target of Rs 12...

Buy quality stocks on dips: like consumer, pharma: Expert 

11.51 am | 24 Sep 2014 |  Source: CNBC-TV18

Market Analyst Satish Ramanathan Ramanathan says Indian investors should have a decent coverage of largecap companies and should buy quality stocks on...

Top10: Stocks to focus on September 24 

8.39 am | 24 Sep 2014 |  Source: CNBC-TV18

Here are Top 10 stocks to focus on September 24 -Unitech, Idea, JSPL, Hindalco, Reliance Power, Educomp, SKS Micro, JSW Energy, Cipla and LML...

Prefer Cipla, Cadilla Healthcare: Sandeep Bhatia 

12.32 pm | 22 Sep 2014 |  Source: CNBC-TV18

According to Sandeep Bhatia, Executive Director & Head of Sales at Kotak Institutional Equities, one may prefer Cadilla Healthcare and Cipla from the ...

Pharma sector could trend in second half: Kotak 

12.12 pm | 22 Sep 2014 |  Source: CNBC-TV18

Sandeep Bhatia, Executive Director & Head of Sales at Kotak Institutional Equities says one should continue to hold on to big pharma names....

Prabhudas Lilladher has Cipla as top pick 

10.46 am | 22 Sep 2014 |  Source: CNBC-TV18

Discussing the stock, Surajit Pal, Pharma Analyst at Prabhudas Lilladher, which has Cipla among its top picks, said that Cipla model is devoid of comp...

Hold Sun Pharma; may test Rs 855-860: Akshata Deshmukh 

3.02 pm | 19 Sep 2014 |  Source: CNBC-TV18

Akshata Deshmukh of Networth Stock Broking is of the view that one may hold Sun Pharmaceutical Industries....

Cipla up 2%, grants exclusive rights to Salix for drug

12.09 pm | 19 Sep 2014 |  Source: Moneycontrol.com

Under the agreement, Cipla has granted Salix exclusive rights for certain patent applications in the ‘Rifaximin Complexes’ patent family controlle...

Here are top 10 stocks to focus on Sep 19 

8.41 am | 19 Sep 2014 |  Source: CNBC-TV18

Here are top 10 stocks to focus on Sep 19 - SBI, HDFC, JP Power, Amara Raja, GVK Power, Cipla, Redington, Sundram Fin, UPL and Polaris....

Stocks in news: Tata Motors, GTL Infra, ICICI, Cipla, SPML

8.22 am | 19 Sep 2014 |  Source: CNBC-TV18

Tata Motors | Tata Chemicals | Tata Steel | Tata Power | Tech Mahindra | Bosch | GTL Infrastructure | SBI | Axis Bank | ICICI Bank | Manappuram Financ...

Cipla grants Salix rights for Rifaximin

8.24 pm | 18 Sep 2014 |  Source: PTI

Commenting on the development, Cipla USA and Canada CEO Timothy Crew said: "We are delighted to be partnering with Salix Pharmaceuticals and to expan...

Cipla licenses rights for innovative product to Salix

7.18 pm | 18 Sep 2014 |  Source: PTI

"Under the agreement, Cipla has granted Salix exclusive rights under certain patent applications in the 'Rifaximin Complexes' patent family controlled...

1 2 3 4 5 6
Quick Links for Cipla
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.